Nov 5, 7:05 AM ET
Zoetis Inc. reported third-quarter 2026 revenue of $2.4 billion, down 1% reported, alongside an 18% decrease in net income to $591 million. The company narrowed its full-year 2026 revenue guidance to a range of $9.220 billion to $9.320 billion while raising its adjusted diluted EPS guidance to a range of $6.25 to $6.35.
- Q3 2026 revenue decreased 1% reported to $2.4 billion.
- Q3 2026 net income decreased 18% reported to $591 million.
- Full-year 2026 revenue guidance narrowed to $9.220 billion to $9.320 billion.
- Full-year 2026 adjusted diluted EPS guidance raised to $6.25 to $6.35.
Read the filing on SEC.gov ↗
Oct 13, 7:32 AM ET
Zoetis said its Board of Directors appointed Iris Knobloch as a director, effective December 1, 2026, and increased the Board from twelve to thirteen members. She will serve on the Corporate Governance Committee. The filing describes a board addition and does not include financial results or guidance.
- Board appointed Iris Knobloch on October 8, 2026; her seat takes effect December 1, 2026.
- Board size increases from twelve to thirteen members effective December 1, 2026.
- Knobloch will serve on the Corporate Governance Committee and is eligible for the non-employee director compensation program.
- She is President of the Festival de Cannes and Chair of the Board of Deezer S.A.; she also sits on the boards of Lazard, Inc. and Vail Resorts, Inc.
Read the filing on SEC.gov ↗
Aug 6, 4:17 PM ET
Zoetis appointed James (Jay) Saccaro, formerly CFO of GE HealthCare, as Executive Vice President, Chief Financial Officer and Chief Operating Officer, effective August 17, 2026. Current CFO Wetteny Joseph will move to a non-executive advisory role and remain with the company until February 28, 2027 or an earlier mutually agreed date. The change puts the finance function and Global Manufacturing and Supply under one executive.
- Saccaro's offer letter, dated July 31, 2026, sets a base salary of $1 million and a target annual incentive of 100% of base salary.
- Saccaro's annual target long-term incentive is $5 million, and he receives one-time make-whole awards of $6.25 million in restricted stock units and $1.25 million in cash.
- Joseph's role as CFO ends after August 16, 2026, or a later date set by the company; his separation benefits follow the Executive Severance Plan.
- Saccaro will serve as principal financial officer and principal accounting officer.
Read the filing on SEC.gov ↗
Aug 6, 7:06 AM ET
Zoetis reported flat second-quarter 2026 revenue of $2.5 billion and net income of $691 million, or $1.65 per diluted share, up 1% on a reported basis. The company also cut its full-year 2026 guidance: revenue is now $9.120 billion to $9.320 billion, down from $9.680 billion to $9.960 billion, and adjusted diluted EPS is now $6.15 to $6.25, down from $6.85 to $7.00. The cut reflects a weaker Companion Animal market, which the company said was affected by lower clinic visits, pet owner price sensitivity and heightened competition.
- Q2 2026 revenue was $2.5 billion, flat versus Q2 2025; U.S. segment revenue fell 7% while International rose 8% on a reported basis.
- Q2 2026 adjusted net income was $781 million, or $1.87 per diluted share, down 1% and up 5% respectively on a reported basis.
- Full-year 2026 revenue guidance was revised to $9.120 billion to $9.320 billion, organic operational growth of (3)% to (1)%, versus prior guidance of 2% to 5%.
- Full-year 2026 adjusted diluted EPS guidance was revised to $6.15 to $6.25, down from $6.85 to $7.00; reported diluted EPS guidance is $5.55 to $5.65.
Read the filing on SEC.gov ↗
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
